Education
About Us
Working with TipRanks
Follow Us
OnKure Therapeutics (OKUR)
NASDAQ:OKUR
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ -50.00K | $ -37.00K |
| Operating Income | $ -54.39M | $ -36.93M | $ -29.77M | $ -39.82M | $ -19.55M |
| EBITDA | $ -51.71M | $ -34.75M | $ -29.38M | $ -39.72M | $ -19.43M |
| Net Income | $ -52.67M | $ -35.31M | $ -29.51M | $ -39.77M | $ -19.46M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 110.76M | $ 29.88M | $ 11.54M | $ 147.67M | $ 53.61M |
| Total Assets | $ 114.91M | $ 35.73M | $ 16.00M | $ 154.02M | $ 55.22M |
| Total Debt | $ 1.08M | $ 674.00K | $ 637.00K | $ 0.00 | $ 92.72M |
| Net Debt | $ -109.68M | $ -29.20M | $ -10.91M | $ -124.66M | $ 39.11M |
| Total Liabilities | $ 11.08M | $ 137.58M | $ 70.42M | $ 6.81M | $ 97.34M |
| Stockholders' Equity | $ 103.83M | $ -101.84M | $ -54.42M | $ 147.21M | $ -42.12M |
| Cash Flow | |||||
| Free Cash Flow | $ -51.17M | $ -34.79M | $ -28.09M | $ -38.18M | $ -18.56M |
| Operating Cash Flow | $ -51.12M | $ -34.55M | $ -26.95M | $ -37.98M | $ -18.54M |
| Investing Cash Flow | $ 15.87M | $ -246.00K | $ -1.13M | $ -23.38M | $ 7.38M |
| Financing Cash Flow | $ 116.13M | $ 53.13M | $ 26.46M | $ 132.41M | $ 47.27M |